Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PDE4 inhibitors(Phosphodieterase 4 inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Preclinical | CN | 15 Mar 2024 |